Read more:
CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day
Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome
ObsEva Announces Proposed Changes to the Composition of its Board of Directors
Immutep Announces Advancement Of Phase II Trial For Eftilagimod Alpha In Covid-19 Patients To Randomised Portion Of The Study
Tiziana Life Sciences plc ("Tiziana" or the "Company") – Tiziana Files Registration Statement on Form F-3 with U.S. Securities and…
Codiak Reports Positive Initial Phase 1 Results for exoIL-12™ Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy…
AzurRx BioPharma CEO Issues Letter to Shareholders
Kiadis issues options to newly hired employees to meet its existing obligations
Here is the original post:
Kiadis issues options to newly hired employees to meet its existing obligations
Todos Medical Announces Positive In Vitro Data for Tollovid™ Confirming 3CL Protease Inhibition Mechanism of Action
Resverlogix Files Notice of Annual and Special Meeting of Shareholders
See the rest here:
Resverlogix Files Notice of Annual and Special Meeting of Shareholders
Crinetics Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference
Read more from the original source:
22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference
Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease
Aeterna Zentaris Reports Third Quarter 2020 Financial Results and Provides Business Update
View original post here:
Aeterna Zentaris Reports Third Quarter 2020 Financial Results and Provides Business Update
Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights
See the original post:
Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights
Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial of LSALT peptide to Treat Complications from Covid-19
Biosyent Announces Launch of New FeraMAX® Pd Therapeutic 150
View original post here:
Biosyent Announces Launch of New FeraMAX® Pd Therapeutic 150
Nobilis Therapeutics to Present at CapCon 2020 Venture Conference
Cara Therapeutics to Announce Third Quarter 2020 Financial Results on November 9, 2020
Continue reading here:
Cara Therapeutics to Announce Third Quarter 2020 Financial Results on November 9, 2020
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
Go here to see the original:
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19